Cannabis / CBD
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. The Current Schedule I Barrier: How Federal Classification Stifles Pediatric Research Because cannabis remains a Schedule I drug, any researcher who wants to study it
Cannabis / CBD
Imagine reaching for a gummy that promises calm without the headache of a surprise drug test. In 2024, more consumers are turning to CBD edibles, but the market remains a minefield of mislabeled products and hidden contaminants. Why Lab Testing Is the First Line of Defense Lab testing separates trustworthy
Cannabis / CBD
When the Texas Senate voted to move cannabis from Schedule I to Schedule II in March 2024, the decision rippled far beyond the headlines. For scientists chasing cures for ultra-rare conditions, the change feels like a new highway opening after years of detours. Below, we walk through the practical steps
Cannabis / CBD
When a police raid nets a truckload of high-THC flower, the headline number - $1.3 million - can feel like a jackpot. Yet for a city juggling a $1.8 billion budget, that windfall is less a lottery win and more a puzzle piece that could reshape spending priorities.